ArticleAlimentary pharmacology & therapeutics2018

Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease.

K T Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.